why choose us

First received: October 21, 2022

Clinical Trial: Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chemotherapy-induced Peripheral Neuropathy

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 2 Study to Assess the Efficacy and Safety of ATX01 (Topical Amitriptyline Hydrochloride 10% and 15% w/w) in Comp

Brief Summary: The purpose of this clinical trial is to compare the efficacy of twice daily applications of ATX01 (10% & 15%) versus placebo during a 12-week treatment period in treating chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivor patients.

Read more